| Issue Date | Title | Author(s) |
| 2004 | Participation versus education: The GISSI story and beyond | Tavazzi L; Maggioni AP; Tognoni G |
| 2004 | A phase II, double blind, randomised, placebo-controlled, dose comparative study of the efficacy, tolerability, and safety of MCC-135 in subjects with chronic heart failure, NYHA class II/III (MCC-135-GO1 study): rationale and design | Zile M; Gaasch W; Little W; Francis G; Tavazzi L; Cleland J; Davies M |
| 2006 | Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study | Daly CA; De Stavola B; Sendon JL; Tavazzi L; Boersma E; Clemens F; Danchin N; Delahaye F; Gitt A; Julian D; Mulcahy D; Ruzyllo W; Thygesen K; Verheugt F; Fox KM |
| 2007 | Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial | Richardson M; Freemantle N; Calvert MJ; Cleland JGF; Tavazzi L |
| 2006 | Predictors of adverse outcome among patients with hypertension and coronary artery disease | Pepine CJ; Kowey PR; Kupfer S; Kolloch RE; Benetos A; Mancia G; Coca A; Cooper De Hoff RM; Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin AC; Tavazzi L |
| 2005 | Predictors of response to cardiac resynchronization therapy (PROSPECT) - study design | Yu CM; Abraham WT; Bax J; Chung E; Fedewa M; Ghio S; Leclercq C; Leon AR; Merlino J; Nihoyannopoulos P; Notabartolo D; Sun JP; Tavazzi L |
| 2006 | Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: Results of the BRING-UP 2 Study | Opasich C; Boccanelli A; Cafiero M; Cirrincione V; Del Sindaco D; Di Lenarda A; Di Luzio S; Fagglano P; Frigerio M; Lucci D; Porcu M; Pulignano G; Scherillo M; Tavazzi L; Maggioni AP |
| 2004 | The ranolazine clinical experience | Tavazzi L |
| 2006 | Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence | Disertori M; Latini R; Maggioni AP; Delise P; Di Pasquale G; Franzosi MG; Staszewsky L; Tognoni G; Tavazzi L; Landolina M |
| 2004 | Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure | Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M |
| 2005 | Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction) | Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L |
| 2007 | Removal of BNP and inflammatory cytokines by haemodiafiltration in refractory heart failure - Reply | Libetta C; Sepe V; Zucchi M; Pisacco P; Cosmai L; Meloni F; Campana C; Rampino T; Monti C; Tavazzi L; Dal Canton A |
| 2004 | Rescreening of "healthy" relatives of patients with dilated cardiomyopathy indentifies subgroups at risk of developing the disease | Repetto a; Serio A; Pasotti M; Fontana a; Bertoletti a; Scelsi l; Magrini g; Monti l; Campana c; Ghio s; Tavazzi L; Arbustini e |
| 2007 | Resting heart rate in cardiovascular disease | Fox K; Borer JS; Camm AJ; Danchin N; Ferrari R; Sendon JLL; Steg PG; Tardif JC; Tavazzi L; Tendera M |
| 2005 | Right ventricular dysfunction in advanced heart failure | Ghio S; Tavazzi L |
| 2005 | Right ventricular functional recovery after acute myocardial infarction: relation with left ventricular function and interventricular septum motion GISSI-3 echo substudy | Popescu BA; Antonini Canterin F; Temporelli PL; Giannuzzi P; Bosimini E; Gentile F; Maggioni AP; Tavazzi L; Piazza R; Ascione L; Stoian I; Cervesato E; Popescu AC; Nicolosi GL |
| 2004 | Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL) | Mann DL; McMurray JJV; Packer M; Swedberg K; Borer JS; Colucci WS; Djian J; Drexler H; Feldman A; Kober L; Krum H; Liu P; Nieminen M; Tavazzi L; Van Veldhuisen DJ; Waldenstrom A; Warren M; Westheim A; Zannad F; Fleming T |
| 2005 | The task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology: Guidelines for the diagnosis and treatment of chronic heart failure: Reply | Swedberg K; Cleland J; Dargie H; Drexler H; Follath F; Komajda M; Smiseth O; Tavazzi L |
| 2005 | Therapeutic approach in patients with stable angina | Lettino M; Falcone C; Tavazzi L |
| 2004 | Tissue Doppler and cardiac resynchronisation therapy: a new challenge for the optimal choice of candidates: Reply | Ghio S; Tavazzi L |
